Table 1 Patient demographic information.
From: Survival improvement for patients with metastatic colorectal cancer over twenty years
Total patients | 1420 (100%) |
Age in years, median [range] | 55.8, [20–98] |
Gender | |
Male | 815 (57%) |
Female | 605 (43%) |
Race | |
Black or African American | 186 (13%) |
Hispanic or Latino | 180 (13%) |
Asian | 96 (7%) |
White or Caucasian | 902 (63%) |
Comorbidities | |
Cardiovascular | 157 (11%) |
Depression | 151 (11%) |
Chronic Kidney Disease | 97 (7%) |
Thyroid Disease | 143 (10%) |
Hypertension | 682 (48%) |
Hyperlipidemia | 355 (25%) |
Diabetes | 279 (20%) |
Therapy | |
Immunotherapy | 69 (5%) |
Anti-EGFR | 384 (27%) |
Anti-BRAF | 20 (1%) |
Regorafenib or Tri/Ti | 142 (10%) |
Liver resection | |
Yes | 153 (11%) |
No | 1267 (89%) |
MSI-Status | |
MSS | 758 (53%) |
MSI-H | 29 (2%) |
